Liver failure due to chronic hepatitis C with hyperthyroidism: a case report
-
摘要: <正>1病例资料患者女性,50岁,因"抗-HCV阳性11个月,尿黄7 d"于2015年6月3日入院。既往23年前行"剖宫产"手术,有输血史。患者2014年7月体检发现抗-HCV阳性,HCV RNA 5.2×106IU/ml,肝功能正常,甲状腺功能四项示促甲状腺激素(thyroid stimulating hormone,TSH)稍低,余正常。给予聚乙二醇干扰素(PEG-IFN)α-2b 80μg/周联合利巴韦林900 mg/d抗
-
Key words:
- hepatitis C /
- chronic /
- hyperthyroidism /
- liver failure
-
[1] FRIEDRICH-RUST M,THEOBALD J,ZEUZEM S,et al.Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic Hepatitis C[J].Viral Hepatol,2009,16(3):168-177. [2] VEZALI E,ELEFSINIOTIS L,MIHAS C,et al.Thyroid dysfunction in patients with chronic hepatitis C:virus-or therapy-related?[J].J Gastroenterol Hepatol,2009,24(6):1024-1029. [3] VASILIADIS T,ANAGNOSTIS P,NALMPANTIDIS G,et al.Thyroid dysfunction and long-term outcome during and after interferon-alpha therapy in patients with chronic hepatitis C[J].Ann Acad Med Singapore,2011,40(9):394-400. [4]MENCONI F,HASHAM A,TOMER Y.Environmental triggers of thyroiditis:hepatitis C and interferon-α[J].J Endocrinol Invest,2011,34(1):78-84. [5]ZHOU M,SUO YJ.A comparative study on standardized131I therapy in patients with Grave’s hyperthyroidism at different age ranges[J].J Clin Exp Med,2015,14(21):1798-1801.(in Chinese)周敏,索艳君.标准化131I治疗不同年龄段Grave’s甲亢的对比研究[J].临床和实验医学杂志,2015,14(21):1798-1801. [6]HU B,SHI LH,TANG CB,et al.Study on the pathogen of postcholecystectomy syndrome non-induction by comcretion and tumor and the measurement of prevention and cure[J].N Chin Coal Med Coll,2005,7(1):11-12.(in Chinese)胡兵,石丽红,唐采白,等.非结石及肿瘤因素胆囊切除术后综合征的病因及防治[J].华北煤炭医学院学报,2005,7(1):11-12. [7]JIANG NY,KUANG AR,TAN J,et al.Interpretation of experts consensus on131I therapy of Graves’s hyperthyroidism(2010)[J].Chin J Nucl Med,2010,30(5):346-351.(in Chinese)蒋宁一,匡安仁,谭建,等.131I治疗Graves甲亢专家共识(2010年)[J].中华核医学杂志,2010,30(5):346-351. [8] TRAN HA,ATTIA JR,JONES TL,et al.Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C under going combination therapy:a nested case control study[J].BMC Endocr Disord,2011,11(1):10.
本文二维码
计量
- 文章访问数: 1520
- HTML全文浏览量: 15
- PDF下载量: 408
- 被引次数: 0